Prostaglandin E2 enhances long-term repopulation but does not permanently alter inherent stem cell competitiveness.

Jonathan Hoggatt, Khalid Mohammad, Pratibha Singh, Louis Pelus

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Hematopoietic stem cell (HSC) transplantation is a lifesaving therapy for malignant and nonmalignant hematologic diseases and metabolic disorders. Although successful, hematopoietic transplantation can be hindered by inadequate stem cell number or poor engrafting efficiency. To overcome these deficits, we and others have previously reported the HSC-enhancing ability of a short-term exposure of prostaglandin E2 (PGE2); this strategy has now progressed to phase 1 clinical trials in double cord blood transplantation. To further analyze the short- and long-term effects of HSC exposure to PGE2, we followed the repopulation kinetics of PGE2-treated hematopoietic grafts through 5 serial transplantations and compared inherent long-term competitiveness in a HSC head-to-head secondary transplantation model. Treatment with PGE2 did not result in a long-term increase in HSC competitiveness, lineage bias, or enhanced proliferative potential, demonstrating that pulse exposure to PGE2 results in transient increases in HSC homing and engraftment potential.

Original languageEnglish (US)
Pages (from-to)2997-3000
Number of pages4
JournalBlood
Volume122
Issue number17
StatePublished - Oct 24 2013

Fingerprint

Hematopoietic Stem Cells
Stem cells
Dinoprostone
Stem Cells
Transplantation
Clinical Trials, Phase I
Hematologic Diseases
Hematopoietic Stem Cell Transplantation
Cell Lineage
Fetal Blood
Transplantation (surgical)
Cell Count
Grafts
Transplants
Blood
Therapeutics
Kinetics

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology
  • Medicine(all)

Cite this

Prostaglandin E2 enhances long-term repopulation but does not permanently alter inherent stem cell competitiveness. / Hoggatt, Jonathan; Mohammad, Khalid; Singh, Pratibha; Pelus, Louis.

In: Blood, Vol. 122, No. 17, 24.10.2013, p. 2997-3000.

Research output: Contribution to journalArticle

Hoggatt, Jonathan ; Mohammad, Khalid ; Singh, Pratibha ; Pelus, Louis. / Prostaglandin E2 enhances long-term repopulation but does not permanently alter inherent stem cell competitiveness. In: Blood. 2013 ; Vol. 122, No. 17. pp. 2997-3000.
@article{7313aaa018264b50ae4b37c8e606cc6f,
title = "Prostaglandin E2 enhances long-term repopulation but does not permanently alter inherent stem cell competitiveness.",
abstract = "Hematopoietic stem cell (HSC) transplantation is a lifesaving therapy for malignant and nonmalignant hematologic diseases and metabolic disorders. Although successful, hematopoietic transplantation can be hindered by inadequate stem cell number or poor engrafting efficiency. To overcome these deficits, we and others have previously reported the HSC-enhancing ability of a short-term exposure of prostaglandin E2 (PGE2); this strategy has now progressed to phase 1 clinical trials in double cord blood transplantation. To further analyze the short- and long-term effects of HSC exposure to PGE2, we followed the repopulation kinetics of PGE2-treated hematopoietic grafts through 5 serial transplantations and compared inherent long-term competitiveness in a HSC head-to-head secondary transplantation model. Treatment with PGE2 did not result in a long-term increase in HSC competitiveness, lineage bias, or enhanced proliferative potential, demonstrating that pulse exposure to PGE2 results in transient increases in HSC homing and engraftment potential.",
author = "Jonathan Hoggatt and Khalid Mohammad and Pratibha Singh and Louis Pelus",
year = "2013",
month = "10",
day = "24",
language = "English (US)",
volume = "122",
pages = "2997--3000",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "17",

}

TY - JOUR

T1 - Prostaglandin E2 enhances long-term repopulation but does not permanently alter inherent stem cell competitiveness.

AU - Hoggatt, Jonathan

AU - Mohammad, Khalid

AU - Singh, Pratibha

AU - Pelus, Louis

PY - 2013/10/24

Y1 - 2013/10/24

N2 - Hematopoietic stem cell (HSC) transplantation is a lifesaving therapy for malignant and nonmalignant hematologic diseases and metabolic disorders. Although successful, hematopoietic transplantation can be hindered by inadequate stem cell number or poor engrafting efficiency. To overcome these deficits, we and others have previously reported the HSC-enhancing ability of a short-term exposure of prostaglandin E2 (PGE2); this strategy has now progressed to phase 1 clinical trials in double cord blood transplantation. To further analyze the short- and long-term effects of HSC exposure to PGE2, we followed the repopulation kinetics of PGE2-treated hematopoietic grafts through 5 serial transplantations and compared inherent long-term competitiveness in a HSC head-to-head secondary transplantation model. Treatment with PGE2 did not result in a long-term increase in HSC competitiveness, lineage bias, or enhanced proliferative potential, demonstrating that pulse exposure to PGE2 results in transient increases in HSC homing and engraftment potential.

AB - Hematopoietic stem cell (HSC) transplantation is a lifesaving therapy for malignant and nonmalignant hematologic diseases and metabolic disorders. Although successful, hematopoietic transplantation can be hindered by inadequate stem cell number or poor engrafting efficiency. To overcome these deficits, we and others have previously reported the HSC-enhancing ability of a short-term exposure of prostaglandin E2 (PGE2); this strategy has now progressed to phase 1 clinical trials in double cord blood transplantation. To further analyze the short- and long-term effects of HSC exposure to PGE2, we followed the repopulation kinetics of PGE2-treated hematopoietic grafts through 5 serial transplantations and compared inherent long-term competitiveness in a HSC head-to-head secondary transplantation model. Treatment with PGE2 did not result in a long-term increase in HSC competitiveness, lineage bias, or enhanced proliferative potential, demonstrating that pulse exposure to PGE2 results in transient increases in HSC homing and engraftment potential.

UR - http://www.scopus.com/inward/record.url?scp=84891689160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891689160&partnerID=8YFLogxK

M3 - Article

C2 - 24047650

AN - SCOPUS:84891689160

VL - 122

SP - 2997

EP - 3000

JO - Blood

JF - Blood

SN - 0006-4971

IS - 17

ER -